Madhu Mazumdar, PhD
- DIRECTOR, INSTITUTE FOR HEALTH CARE DELIVERY SCIENCE
- PROFESSOR | Population Health Science and Policy
- PROFESSOR | Orthopedics
Dr. Mazumdar developed methodologies for detecting publication bias in meta-analysis; for adjusting selection bias in clinical trials; for allowing interim looks at data in clinical trials comparing diagnostic tests; for developing and validating quality of life questionnaire; and for estimating misclassification rate of responders when oncologic response criteria were changed. Her collaborative research resulted in personalized treatment regimen for various cancer types and orthopedic surgeries. Her work also changed guidelines for staging cancer and practice guidelines for use of anesthetics. She developed innovative interdisciplinary educational and research programs, in collaboration with various clinical departments that increased productivity through grantsmanship and augmented clinical revenue through improved care delivery. Working within inter-disciplinary teams, she has trained more than 50 biostatisticians, epidemiologists, and clinical researchers, many of whom are leading quantitative science units today.
Education
MA, University of Delhi
MS, University of Pittsburgh
PhD, Penn State University
Fellowship, Drexel University
-
2013
Fellow -
2012
Team Science Award -
2008
Fellow
Research Topics
Methodology Areas: Meta-analysis, Comparative Effectiveness Research, Clinical Trial Design, Prognostic and Predictive modeling,
Clinical Research Areas: Oncology, Anesthesiology, Radiology, Surgery
Teaching:
Biostatistics Module, MS in Healthcare Delivery Science and Leadership, ISMMS
Clinical Trials Design Workshop: Organized by the Radiological Society of North America, a Clinical Research Training Institute Summer Workshop: Organized by the American Society of Hematology
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mazumdar did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.